{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T02:36:47Z","timestamp":1771295807060,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T00:00:00Z","timestamp":1483920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jdcr.2017.01.006","type":"journal-article","created":{"date-parts":[[2017,3,12]],"date-time":"2017-03-12T01:15:18Z","timestamp":1489281318000},"page":"127-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ulcerative necrobiosis lipoidica in the setting of anti\u2013tumor necrosis factor-\u03b1 and hydroxychloroquine treatment for rheumatoid arthritis"],"prefix":"10.1016","volume":"3","author":[{"given":"Jennifer Albus","family":"Fehlman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M.","family":"Burkemper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tricia A.","family":"Missall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdcr.2017.01.006_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jaad.2013.05.034","article-title":"Update on necrobiosis lipoidica: A review of etiology, diagnosis, and treatment options","volume":"69","author":"Reid","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdcr.2017.01.006_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.det.2015.03.003","article-title":"Necrobiosis lipoidica","volume":"33","author":"Sibbald","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jdcr.2017.01.006_bib3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.metabol.2015.12.014","article-title":"Anti-TNF \u03b1 treatment for recalcitrant ulcerative necrobiosis lipoidica diabeticorum: A case report and review of the literature","author":"Basoulis","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jdcr.2017.01.006_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000314694","article-title":"Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature","volume":"221","author":"Suarez-Amor","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.jdcr.2017.01.006_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-4632.2010.04149.x","article-title":"Significant improvement in ulcerative necrobiosis lipoidica with hydroxychloroquine","volume":"49","author":"Kavala","year":"2010","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2017.01.006_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/archdermatol.2009.6","article-title":"Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with infliximab: report of a case","volume":"145","author":"Hu","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jdcr.2017.01.006_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/ajd.12420","article-title":"Pentoxifylline: An effective therapy for necrobiosis lipoidica","volume":"58","author":"Wee","year":"2017","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2017.01.006_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/2229-5178.174328","article-title":"Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with oral thalidomide","volume":"7","author":"Shah","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jdcr.2017.01.006_bib9","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/ijd.12309","article-title":"Necrobiosis Lipoidica occurring in a patient with rheumatoid arthritis on concurrent tumor necrosis factor-\u03b1 inhibitor therapy","volume":"54","author":"Chung","year":"2015","journal-title":"Int J Dermatol"},{"issue":"12","key":"10.1016\/j.jdcr.2017.01.006_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5070\/D35TK1D4CP","article-title":"Treatment of necrobiosis lipoidica with etanercept and adalimumab","volume":"15","author":"Zhang","year":"2009","journal-title":"Dermatol Online J"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512617300097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512617300097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:18:04Z","timestamp":1762474684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512617300097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2352512617300097"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2017.01.006","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ulcerative necrobiosis lipoidica in the setting of anti\u2013tumor necrosis factor-\u03b1 and hydroxychloroquine treatment for rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2017.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}